Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is an inheritable cardiac disease characterized by the hypertrophy of the myocardial segments.HCM is the leading cause of sudden cardiac death in young athletic adults in the United States. While the prevalence rate of HCM is 0.2-0.8%, it is widely underdiagnosed. Left ventricle hypertrophy is most observed, but other myocardial segments are also susceptible to hypertrophy. These include anterolateral wall, apex, mid-ventricular, isolated basal septa, and asymmetric interventricular septal hypertrophy. Outcomes in HCM have improved over the years but continue to require access to better therapies in young children, who currently do not have access to myosin inhibitors.